2248142
Last Update Posted: 2014-09-25
Recruiting has ended
All Genders accepted | Under |
1029 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)
Study to evaluate treatment effect of pramipexole on RLS severity as measured by IRLS, CGI-I and RLS-6 and to evaluate the time needed to reach maintenance dose of Pramipexole (PPX)
Eligibility
Relevant conditions:
Restless Legs Syndrome
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov